Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Bexarotene (Primary) ; Interferon alpha-2b (Primary)
- Indications Cutaneous T cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2009 Actual initiation date (Sep 2004) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2005 New trial record.